Annals of the Rheumatic Diseases A journal of clinical rheumatology and connective tissue research This journal, founded by the Empire Rheumatism Council, now the Arthritis and Rheumatism Council for Research in Great Britain and the Commonwealth, is also supported by the Heberden Society. Advice to contributors Communications This journal exists to publish work on all aspects of rheumatology and disorders of connective tissue. Laboratory as well as clinical studies are welcome. In ad- dition brief communications, for example reports of single cases, will be printed if of exceptional interest. Papers, which will be accepted on the understanding that they have not been and will not be published elsewhere and are subject to editorial revision, should be addressed to The Editor, Annals of the Rheumatic Diseases, Kennedy Insti- tute of Rheumatology, Bute Gardens, London W6 7DW. Each author must sign the covering letter as evidence of consent to publication. Two copies should be supplied, one a typed top copy. Authors requiring acknowledgement of papers submitted should enclose a stamped addressed postcard or, if overseas, an international reply paid coupon. Articles must be typewritten on one side of the paper only, in double spacing with ample margins. Only re- cognised abbreviations should be used. Tables should be presented on separate sheets apart from the text. SI units The units in which the work was done will appear first with the other units, i.e. SI or traditional units, appear- ing after in parentheses. With regard to tables and figures, a conversion factor should be given as a footnote. References In accordance with the Vancouver agreement references, which must be typed doubled spaced, are cited by the numerical system. A paper (or book) cited in the text is referred to there by a superscript number. In the list of references the papers (or books) appear in the numerical order in which they are first cited in the text, not in alphabetical order by authors' names. For convenience in preparing the typescript the reference number may be typed between parentheses on the line, not superscript. The titles of journals are abbreviated in accordance with the style of Index Medicus. In the type- script they should either be abbreviated in that style or given in full. Three examples follow: 1 Green A B, Brown C D, Grey E F. A new method of measuring the blood glucose. Ann Rheum Dis 1980; 64: 27-9. 2 Green A B, Brown C D. Textbook of Medicine. London: Silver Books, 1980. Grey E F. Diseases of the pancreas. In: Green A B, Brown C D, eds. Textbook of Medicine. London: Silver Books, 1980: 349-62. References will not be checked in the editorial office. Responsibility for their accuracy and completeness lies with the author. Illustrations These should be marked on the back with the author's name, numbered, and the top edge indicated. Separate illustrations should be separately numbered. Only illustrations appearing together in the same block should bear the same number and separate lettering 1 a, 1 b, 1 c, etc. Such letters, together with arrows or other symbols, must be inserted by the author. Photographs should be on glossy paper. Radiographs should be submitted as prints suitable for reproduction. Line drawings should be in black ink on white paper or card and have lettering large enough to be clear when reduced on the page. Legends to illustrations should be typed in double spacing on a separate sheet and those for photomicrographs should include magnification. Tables Each table should be on a separate sheet, have a heading, and contain no vertical rules. Proofs Contributors will receive ONE proof, and should read it carefully for printers' errors. Alterations to the original text should be kept to a minimum and may be charged to the author. Reprints 25 reprints will be supplied free of charge. Ad- ditional reprints may be ordered from the Publishing Man- ager when the proofs are returned. Notice to subscribers The annual subscription rate including postage by surface mail is £28-00 in the United Kingdom and Republic of Ireland, and US $67-00 in all countries overseas. Payment for overseas subscriptions should be made in US dollars, i.e. US $67-00, or in your national currency, based on the prevailing exchange rate to the US dollar of that currency, payable to the British Medical Association. Orders can also be placed locally through any leading subscription agent or bookseller. (For the convenience of readers in the USA subscription orders, with or without payment, can be sent to: BRITISH MEDICAL JOURNAL, 1172 Common- wealth Avenue, Boston, Mass. 02134. All inquiries, how- ever, must be addressed to the publisher in London.) All inquiries regarding air mail rates and single copies already published should also be addressed to the publisher in London. Notice to advertisers Applications for advertisement space and for rates should be addressed to the Advertisement Manager, Annals of the Rheumatic Diseases, B.M.A. House, Tavistock Square, London WC1H 9JR. COPYRIGHT 3 1980 by the Annals of the Rheumatic Diseases This publication is copyright under the Berne Convention and the International Copyright Convention. All rights reserved. Apart from any relaxations permitted under national copyright laws, no part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means without the prior permission of the copyright owners. Permission is not, however, required to copy abstracts of papers or of articles on condition that a full reference to the source is shown. Multiple copying of the contents of the publication without permission is always illegal.
Transcript
Annals of the Rheumatic DiseasesA journal of clinical rheumatology and connective tissue research
This journal, founded by the Empire Rheumatism Council, now the Arthritis and RheumatismCouncil for Research in Great Britain and the Commonwealth, is also supported by theHeberden Society.
Advice to contributors
Communications This journal exists to publish work on allaspects of rheumatology and disorders of connective tissue.Laboratory as well as clinical studies are welcome. In ad-dition brief communications, for example reports of singlecases, will be printed if of exceptional interest.
Papers, which will be accepted on the understanding thatthey have not been and will not be published elsewhere andare subject to editorial revision, should be addressed to TheEditor, Annals of the Rheumatic Diseases, Kennedy Insti-tute of Rheumatology, Bute Gardens, London W6 7DW.Each author must sign the covering letter as evidence ofconsent to publication.Two copies should be supplied, one a typed top copy.
Authors requiring acknowledgement of papers submittedshould enclose a stamped addressed postcard or, if overseas,an international reply paid coupon.
Articles must be typewritten on one side of the paperonly, in double spacing with ample margins. Only re-cognised abbreviations should be used.
Tables should be presented on separate sheets apart fromthe text.
SI units The units in which the work was done will appearfirst with the other units, i.e. SI or traditional units, appear-ing after in parentheses. With regard to tables and figures, aconversion factor should be given as a footnote.
References In accordance with the Vancouver agreementreferences, which must be typed doubled spaced, are citedby the numerical system.A paper (or book) cited in the text is referred to there by a
superscript number. In the list of references the papers (orbooks) appear in the numerical order in which they are firstcited in the text, not in alphabetical order by authors'names. For convenience in preparing the typescript thereference number may be typed between parentheses on theline, not superscript. The titles of journals are abbreviatedin accordance with the style of Index Medicus. In the type-script they should either be abbreviated in that style or givenin full. Three examples follow:
1 Green A B, Brown C D, Grey E F. A new method ofmeasuring the blood glucose. Ann Rheum Dis 1980; 64:27-9.
2 Green A B, Brown C D. Textbook ofMedicine. London:Silver Books, 1980.Grey E F. Diseases of the pancreas. In: Green A B,Brown C D, eds. Textbook of Medicine. London: SilverBooks, 1980: 349-62.References will not be checked in the editorial office.
Responsibility for their accuracy and completeness lies withthe author.Illustrations These should be marked on the back with theauthor's name, numbered, and the top edge indicated.Separate illustrations should be separately numbered. Only
illustrations appearing together in the same block shouldbear the same number and separate lettering 1 a, 1 b, 1 c, etc.Such letters, together with arrows or other symbols, must beinserted by the author. Photographs should be on glossypaper. Radiographs should be submitted as prints suitablefor reproduction. Line drawings should be in black ink onwhite paper or card and have lettering large enough to beclear when reduced on the page. Legends to illustrationsshould be typed in double spacing on a separate sheet andthose for photomicrographs should include magnification.Tables Each table should be on a separate sheet, have aheading, and contain no vertical rules.Proofs Contributors will receive ONE proof, and should readit carefully for printers' errors. Alterations to the originaltext should be kept to a minimum and may be charged to theauthor.Reprints 25 reprints will be supplied free of charge. Ad-ditional reprints may be ordered from the Publishing Man-ager when the proofs are returned.
Notice to subscribersThe annual subscription rate including postage by surfacemail is £28-00 in the United Kingdom and Republic ofIreland, and US $67-00 in all countries overseas. Paymentfor overseas subscriptions should be made in US dollars, i.e.US $67-00, or in your national currency, based on theprevailing exchange rate to the US dollar of that currency,payable to the British Medical Association. Orders can alsobe placed locally through any leading subscription agent orbookseller. (For the convenience of readers in the USAsubscription orders, with or without payment, can be sentto: BRITISH MEDICAL JOURNAL, 1172 Common-wealth Avenue, Boston, Mass. 02134. All inquiries, how-ever, must be addressed to the publisher in London.)
All inquiries regarding air mail rates and single copiesalready published should also be addressed to the publisherin London.
Notice to advertisersApplications for advertisement space and for rates shouldbe addressed to the Advertisement Manager, Annals oftheRheumatic Diseases, B.M.A. House, Tavistock Square,London WC1H 9JR.
COPYRIGHT 3 1980 by theAnnals of the Rheumatic Diseases
This publication is copyright under the Berne Conventionand the International Copyright Convention. All rightsreserved. Apart from any relaxations permitted undernational copyright laws, no part of this publication may bereproduced, stored in a retrieval system, or transmitted inany form or by any means without the prior permission ofthe copyright owners. Permission is not, however, requiredto copy abstracts of papers or of articles on condition that afull reference to the source is shown. Multiple copying of thecontents of the publication without permission is alwaysillegal.
December 1980 Volume 39 No 6
Annals of theRheumatic Diseases
A journal of clinical rheumatology andconnective tissue research
EDITOR J. T. Scott
ASSOCIATE EDITORS H. L. F. Currey V. Wright
EDITORIAL COMMITME
B. M. Ansell John Ball C. G. Barnes E. G. L. BywatersA. M. Denman J. T. Dingle A. St. J. Dixon D. C. DumondeR. B. Duthie D. L. Gardner E. B. D. Hamilton E. J. HolborowG. R. V. Hughes D. Jackson A. G. Mowat G. Nuki K. W. WaltonP. H. N. WoodEditor British Medical Journal
Appointed by the British Medical Association and theArthritis and Rheumatism Council for Research
TECHNICAL EDITOR T. D. V. Swinscow
This journal publishes papers on all aspects of rheumatology and disordersofconnective tissue. Laboratory as well as clinical studies are welcome.In addition brief communications, for example reports of single cases, willbe printed if of exceptional interest.
PUBLISHED SIX TIMES A YEAR
British MedicalAssociation Tavistock Square LondonWC1H9JR
from patients who had been treated with radioactivecolloid and to relate the observations with studies madepreviously in this department on the movement ofradioactivity in patients following knee injections.Comments on the points raised are as follows.
(1) The synovial membranes, as received for measure-ment, showed no evidence of surface fibrin. Clearly ifisotope is deposited on fibrin this may contribute touneven uptake by the synovial membrane itself.
(2) Uptake of radioisotope by fibrin bodies woulddecrease the total amount available for uptake by thesynovial membrane but would not by itself cause unevenuptake. Obviously uptake on fibrin bodies would reducethe total radioactivity found on portions of synovialmembrane subsequently excised; to what extent it isimpossible to estimate.
(3) The same argument applies. In fact, neither patienthad sizeable Baker's cysts.
Correspondence 615
(4) Without doubt a considerable portion of synovialmembrane was not removed at surgery, but, as pointedout in the paper, this could hardly account for findingonly 10% of what would be expected, allowing for decay,in the synovial membrane which was removed.
(5) We did not suggest that further leakage does notoccur after the sixth day, and our findings indicate thatit may indeed occur. However, we have found frommeasurements on several patients that the knee activitytends to approach a stable value by about the sixth dayand that the escape is not exponential after about thefourth day.
P. B. DUNSCOMBEN. W. RAMSEY
Department ofMedical Physics,Charing Cross Hospital,
Fulham Palace Road,London W6 8RF.
Notes
15th International Congress ofRheumatology
Spanish postgraduate course inrheumatology
The 15th International Congress of Rheumatology willtake place in Paris on 21-27 June 1981. The principalthemes will be: inflammatory rheumatism in adults,juvenile chronic arthritis, collagen diseases, arthrosis ofthe limbs, microcrystalline arthritis, metabolism osteo-pathy, abarticular rheumatism, and mechanical spinal-column pathology. Special sessions will be devoted tothe activities of the standing committees of the Inter-national League against Rheumatism and the results ofthe scientific and applied research work of the pharma-ceutical industry. A scientific exhibition will give anopportunity for the presentation of posters, films, andcollections of slides. The official languages will beEnglish, Spanish, and French, with simultaneoustranslation. The final date for sending in abstracts is31 January 1981. Further information from CongresIntemational de Rhumatologie B.P. 443-08, 75366Paris, Cedex, France; and, on the scientific programmeonly, from Professor J. Villiaumey, Service de Rhuma-tologie, Hopital Henri-Mondor, 94010 Creteil Cedex,France.
A postgraduate course in rheumatology will be held inBarcelona on 23-27 February 1981. Details from theCourse Secretary, J. J. Molina, Plaza Eguilas 14 (esq.calle Buigas), Barcelona 17, Spain.
Clinical trialsThe combined annual scientific sessions of the Societyfor Clinical Trials and the eighth annual symposium forCo-ordinating Clinical Trials will be held on 11-13 May1981 at San Francisco, California. The sessions will focuson the design, organisation, management, and analysesof clinical trials. Abstracts must be received by 1 January1981. Information from Christian R. Klimt, MD, Secre-tary Society for Clinical Trials Inc., 600 WyndhurstAvenue, Baltimore, Maryland 21210, USA.
Annals of the Rheumatic Diseases, 1980, 39, 616-631
INDEX TO VOLUME 39, 1980P. Proceedings of the Heberden Society
AAIJ C see SMIT J W et alAASETH J see JELLUM E et alABBo-TILSTRA B see VAN DE STADT R JABRAHAM A A and Joos A Pancreatic necrosis in
progressive systemic sclerosis: case report, 396Acne fulminans associated with destructive arthritis:
case report, 403Acute phase proteins, serum, and ESR, effect of ICI
55 897 in rheumatoid arthritis, 18Aid for developing countries: viewpoint, 411AITKEN L C see MOWAT A G et alAKYOL S, MACKLON A F, GRIFFITHS I D, THOMPSON M
and JAMES 0 Rheumatological and serologicalfeatures of primary biliary cirrhosis 186 P
ALARCON-SEGOVIAD Descriptions of therapeutic arthro-centhesis and of synovial fluid in a Nahuatl textfrom prehispanic Mexico 291
Alclofenac and D-penicillamine in rheumatoid arthritis,biochemical comparison, 281
ALDo-BENSON M A see EYANSON S et alALEA J A see COSTELLO P B et alALEXANDER G J M, SCOTT D G I, JONES H, and DIEPPE
P A Pyrophosphatase arthropathy-a clinicalstudy 605 P
ALLEN C, ELSON C I, SCOTT D G I and BACON P AIgG antiglobulins in RA and other arthritides 191 P
ALLISON D J see SEWELL J R et alALLEN C, see JONES V E et al,
SCOTT D G I et alAllopurinol treatment and renal function in gout, 188 PALTHOFF B and GOLDIE I F Cervical collars in rheuma-
toid atlanto-axial subluxation: a radiographiccomparison 485
ALTMAN D G see GUMPEL J M et alAMOS R S see MCCONKEY B et alAmyloid protein levels, serum, South American children
with rheumatoid arthritis, 228Amyloidosis and gout, 589ANASTASSIADES T P see KEAN W F et alANDRES S Ruiz DE see Ruiz DE ANDRES SAngioimmunoblastic lymphadenopathy associated with
polyarthritis: case report, 406Ankylosing spondylitis
association of inflammation with raised serum IgA in,545
circulating immune complexes in, 445failure to find Clq-binding material and anti-IgG
antibodies, 449
HLA B27, and klebsiella, cross reactivity studies,194 P
incidence of serum antibodies to native types I and IIcollagens in, 201
klebsiella associated with, 606 PC-reactive protein and ESR in, 45aerogenes, faecal, frequency, 37, 118
prevalence of occult inflammatory bowel disease, 453and rheumatoid arthritis, faecal carriage of klebsiella,
37, 118subpopulations ofT lymphocytes, 566T-lymphopenia in, 190PYer-sinia enter-ocolitica, and HLA B27: correspondence,415
Annular tears in the dorsolumbar spine, 533ANSELL B M see CAEIRO F et al
LEAK A M et alSCHWARZ H A et al
Antibiotic concentrations in synovial fluid after oraladministration, 608 P
Antibody(ies)against 10 nm filaments in rheumatoid arthritis, 598 Panti-IgG, and Clq-binding material, in ankylosing
spondylitis, failure to find, 449serum, to native type I and II collagens in inflammatory
Arthritisaseptic, after gonorrhoea, 141asscciated with leucocytoclastic angiitis: case report,
526616
Index 617
destructive, associated with acne fulminans: casereport, 403
dextran sulphate induced, rabbits, 387moraxella infectious, first report in adult: case report,
184septic, due to Pasteurella multicoda: correspondence, 98
synovial fluid abnormalities in detected by gas-liquid chromatography, 168
sexually acquired reactive, Chlamydia trachomatisinfection in, 431
Arthrocentesis, therapeutic, and synovial fluid, descrip-tions in a Nahuatl text from prehispanic Mexico,291
Arthropathyimmune, and hyperlipidaemia, association with connec-
tive tissue diseases, 490pyrophosphate, a clinical study, 605 P
Articularcartilage, effect of homologous synovial membrane on,
failure of D-penicillamine to influence, 53effect of synovium on proteoglycan synthesis by,
196 Pindex for assessment of osteoarthritis, 606Pinvolvement in dominant hand in rheumatoid arthritis,X-ray study, 508
Aspirin, betamethasone and gold salt, comparison ofeffect on chemotaxis of neutrophils, measured invitro, 25
Atlanto-axial subluxation, cervical collars for radio-graphic comparison, 485
Aurothiomalate, intramuscular administration, fate ofthe gold and the thiomalate part, 155
AVAKIAN H see EBRINGER A et alAvascular necrosis of femoral heads in gout and chondro-
calcinosis of knees, frequency, 7AVERSA J M see CooNEY L M et alAzathioprineand cause of death in rheumatoid arthritis, 457in rheumatoid arthritis, double blind study, 604 P
long-term, 605 P
BACON P A see ALLEN C et alBLAKE D R and BACON P AEGHTEDARI A A et alHALL N D et alMORGAN J E et alRASKER J L et alSCOTT D G I et al
BAILEY A J see BLACK C M et alBALINT G see GENTI G et alBALL J see HILTON R C et alBALOGH Z, EL-GHOBAREY A F, FELL G S, BROWN D H,
DUNLOP J and DICK W C Plasma zinc and itsrelationship to clinical symptoms and drugtreatment in rheumatoid arthritis 329
MERETEY K, FALUs A and BOZS6KY S Serologicalabnormalities in juvenile chronic arthritis: a reviewof 46 cases 129
BARBADO J see ARNALICH F et alBARNES C G see HALSEY J P et alBARRETT S J see CAWLEY M I D et alBATCHELOR J R see BERNSTEIN R et al
BAYLISS M T see MAROUDAs A et alBEALES J G, KEEN J H, MELLOR V P, and HOLT P J L
Fantasies about the appearance of affected jointsamong children with juvenile chronic arthritis602 P
BECKER G J, WALDBURGER M, HUGHES G R V andPEPYs M B Value of serum C-reactive proteinmeasurement in the investigation of fever insystemic lupus erythematosus 50
Behret's disease, HLA antigens in, comparison ofTurkish and British patients, 344
BENN R T see HILTON R C et alBENSON M A ALDO- see ALDO-BENSON M ABENSON M D see EYANSON S et al
SCHEINBERG M A et alBERNSTEIN R, HARLAND S, DOLLERY C, BATCHELOR J R,
RYAN P and HUGHFS G R V Hydrallazine lupus194P
see also CAEIRo F et alBERRY H, FORD-HUTCHINSON A W, CAMP A V, HEYWOOD
D, MOLLOY M G, JAMES D W and HAMILTONE D B Antirheumatic activity of fenclofenac 473
Betamethasone, gold salt and aspirin, comparison ofeffect on chemotaxis of neutrophils, measured invitro, 25
BIBERFELD G see NILSSON E and BIBERFELD GBILLINGHAM M E J see MCCONKEY B et alBiopsy, selective, and temporal arteriography, combined,
in suspected giant cell arteritis, 124BIuD H A Systemic effects of intra-articular steroid
preparations: correspondence, 413DIXON J S, PICKUP ME and WRIGHT V A biochemicalcomparison of alclofenac and D-penicillamine inrheumatoid arthritis 281
and WRIGHT V A biochemical study of sulphasalazinein rheumatoid arthritis 603 P
see also RHIND V M et alBITENSKY L see COULTON L A et alBLACK C M, DUANCE V C, DUBOWITZ V, HUGHES G R V
and BAILEY A J Collagen changes in polymyositis186 P
BLAKE D R and BACON P A Ferritin, RE cell, dys-function, and systemic rheumatoid arthritis 597 P
EAsTHAM E J and BACON PA Synovial fluid ferritin inrheumatoid arthritis, 596P
Blood, immunoblasts, in rheumatic diseases, 318BLUESTONE R see BROOK I et alBOOK REVIEWS
BACH G L and SCHILLING F Compendia rheuma-tologica. Kennbilder der wichtigsten rheuma-tischen Erkrangungen 1977 300
DAvIEs D H and NELSON W P Understandingcardiology 1978 611
DHSS report on Working Group on Pain 1979531
DILSEN N, KONICE M and OVUL C editorsBehret's disease 1978 99
DUMONDE D C and STEWARD M W editorsLaboratory tests in rheumatic diseases:standardisation in laboratory and clinicalpractice 1979 613
ELLIOT M Nursing rheumatic disease 1979 613
618 Index
FORRESTER C M, BROWN JC and NESSON JW Theradiology of joint disease, 2nd ed. 1979 610
GOLDING D N editor Concise management of thecommon rheumatic diseases 1979 610
HANISSIAN A S Pediatric rheumatology casestudies 1979 612
HART F D Drug treatment of the rheumaticdiseases 1979 610
HEALEY L A and WnsKE K R The systemicmanifestation of temporal arteritis 1978531
HUSKISSON E C editor Clinics in rheumaticdiseases. Vol. 5. Anti-rheumatic drugs 1979611
International Symposium on Streptococci andStreptococcal Diseases, 7th, PathogenicStreptococci, proceedings, September 1978,Oxford 1979 300
MCCARTY D Arthritis and allied conditions, 9thed, 1979 612
NEUWELT E A and CLARKE W K Clinical aspectsofneuroimmunology 1978 100
PANAYI G S editor Rheumatoid arthritis andrelated conditions, vol. 3 1979 611
PANAYI G S editor Rheumatoid arthritis and rela-ted conditions, vol. 2 1978 99
PANAYI G S and JOHNSON P M editors Immuno-pathogenesis of rheumatoid arthritis 1979613
PARKER, M T editor Pathogenic streptococci1979 300
POLLEY H F and HUNDER G G Rheumatologicinterviewing and physical examination ofthejoints, 2nd ed. 1978 531
Royal Society of Medicine International Congressand Symposium Series 1. Piroxicam 1978532
SAMTER M Immunological diseases 3rd ed vols 1and 2 1978 100
TALBOTT J H editor Clinical rheumatology 1978300
THERON J and MORET J editors Spinal phlebo-graphy: lumbar and cervical techniques1978 532
WHO Immunodeficiency 1978 99BORBAs E see GENTI G et alBOURKE B, Moss I and MAINI R N A quantitative
measurement of complement (C3) activation inSLE and rheumatoid arthritis 601 P
BOYLE A C see CROKER JR et alBoz6SKY S see BALOGH Z et alBRADBY G V H see SCOTTD L et alBRADLEY J see ROBERTS-THOMSON P J et alBRAUMAN H see MANICOURT D et alBreast enlargement and D-penicillamine: correspondence,
200BREWERTON D A see WARREN R E and BREWERTON D A
WEBLEY M et alBRICKNELL K S see BROOK I et al
BROOK I, REZA M J, BRICKNELL K S, BLUESTONE R andFINEGOLD S M Abnormalities in synovial fluid ofpatients with septic arthritis detected by gas-liquid chromatography 168
BROWN D H see BALOGH Z et alBROWN K A, PERRY J F and HOLBOROW E J An electro-
phoretically characterised lymphocyte subpopula-tion increased in rheumatoid arthritis 190P
BURGESS S E P see EASTMOND C J et alBYROM N A see WEBLEY M et alBYWATERS E G L: Conference proceedings wanted:
correspondence, 530see also ELKON K B et al
CAEIRo F, MICHILSON F, BERNSTEIN R, HUGHES G R Vand ANSELL B M Systemic lupus erythematosusin childhood 601 P
Calcium pyrophosphate crystals, formation in vitro,implications in pseudogout, 222
CAMBRIDGE G, STERN C M, SEWELL J R and HUGHESG R V A specific mycocytotoxity assay 190 P
CAMP A V see BERRY H et alCAPELLH A, HUNTER J A, PAPAZOGLOU S, and MURDOCH
R M Is low-dose levamisole (150 mg/week) analternative to gold in the management of rheuma-toid arthritis 602P
CARGILL A F see HALSEY J P et alCARTER B M see DREW S I et alCartilage, femoral head, composition, 514CARVALHO A see JOHNSON G D et alCATS A see MEIJER C J L M et alCAWDELL D see COWLING P et alCAWLEY M I D SArrAR M A and BARRETr S J Antibio-
tic concentrations in synovial fluid after oraladministration 608 P
Cervical collars in rheumatoid atlanto-axial subluxation:radiographic comparison, 485
CHAKRABORTY J see REEBACK J S et alCHAMBERLAIN M A see YAzIcI H et alCHANDRA M see OSUNG 0 A et alCHAPUT DE SAINTONGE D M see WOODLAND J et alCHAYEN J see COULTON L A et al
HENDERSON B et alChemotaxis
neutrophils, effect of one gold salt, of betamethasoneand of aspirin, measured in vitro, 25
in juvenile chronic arthritis, 481polymorphonuclear leucocytes, defective in rheuma-
toid arthritis associated with a serum inhibitor, 68Chlamydia trachomatis infection in sexually acquired
reactive arthritis, 431Chondrocalcinosis of knees and avascular necrosis of
femoral heads in gout, frequency, 7CHRETIANSEN K, HOLMES K and ZILKO P J Metal
relation to hyperlipidaemia and immune arthropathy490
serum immunoreactive prolyl hydroxylase in, 217effect of therapy on virus lymphocyte interactions, 189p
CONSTABLE T J see MCCONKEY B et alCoOKE E M see EASTMOND C J et alCooNEY L M, AVERSA JM and NEWMAN J H Insidious
bilateral infrapatellar tendon rupture in a patientwith severe SLE: case report, 592
CORBETr M see RICHTER M B et alCORRESPONDENCEAcute gout during hypouricaemic therapy: prophylaxis
with colchicine, 529Another look at osteoarthritis, 200Conference proceedings wanted, 530D penicillamine and breast enlargement, 200
Gold binding to blood cells, 529Gold and penicillamine, 98Haemophilus influenzae tenosynovitis, 530HLA B27, Yersinia enterocolitica and ankylosing
spondylitis, 415Implications of a sex difference in osteoarthrosis, 199Pulmonary involvement in SLE, 297Radiation synovectomy with yttrium-90 silicate, 614Septic arthritis due to Pasteurella multocida, 98Standardisation of tests for antinuclear antibody, 529Systemic effects of intra-articular steroid preparations,
413Systemic lupus erythematosus and pulomonary mani-
COSTELLO P B, ALEA J A, KENNEDY A C, MCCLUSKEYR T and GREEN F A Prevalence of occultinflammatory bowel disease in ankylosing spondy-litis 453
COTTON P B see CROKER J R et alCOULTON L A, HENDERSON B, BITENSKY L and CHAYEN J
DNA synthesis in human rheumatoid and non-rheumatoid synovial lining, 241
COuRTOIS C, FALLET G H, VISCHER, T L and WETrsTEINP Erosive spondylopathy 462
COWLING P, EBRINGER R, CAWDELL D, ISHII M andEBRINGER A C-reactive protein, ESR, andklebsiella in ankylosing spondylitis 45
EBRINGER R and EBRINGER A Association of inflam-mation with raised serum IgA in ankylosingspondylitis 545
see also EBRINGER A et alJONES V E et al
CRAIG M MILLAR- see MILLAR-CRAIG MC-reactive protein
effect of ICI 55 897 on in rheumatoid arthritis, 18serum measurement ESR, and klebsiella in ankylosing
spondylitis, 45value in investigation of fever in SLE, 50
CRESPO M S see EGIDO J et alCROCKSON A P see MCCONKEY B et alCROCKSON RA see MCCONKEY B et atCROKER J R, COTTON P B, BOYLE A C and KINSELLA P
Cimetidine for peptic ulcer in patients with arthri-tis 275
Cryoprecipitates, synovial fluid, survey, 253Crystal surface charge and inflammation, 605 PCURREYH L F see WOODLAND J et alCytotoxicity
cell-mediated, for cultured autologous rheumatoidsynovial membrane cells, 570
spontaneous, of rheumatoid and normal peripheralblood mononuclear cells against 4 human lympho-blastoid cell lines, 559
D'AMARO J see YAZICIH et alDARLINGTON L G, SLACK J and SCOTT J T Vascular
mortality in gout patients and their families 189 Psee also STOCKMAN A et al
DAvIS P see RASKER J L et alROTHWELL R S et al
620 Index
DE ANDRES S Ruiz see Ruiz DE ANDRES SDE HAAS E see MEIJER C J L M et alDE PuTTE L B A VAN see VAN DE PUTTE L B ADE SILVA M and HAZLEMAN B L Long-term azathioprine
in rheumatoid arthritis 605 PDE SILVA R T D, GRENNAN D M and PALMER D G
Lymphatic obstruction in rheumatoid arthritis: acause for upper limb oedema 260
DE STADT R J VAN see VAN DE STADT R JDELCAMBRE B see DUQUESNOY B et alDEMERIEUX P, KEYSTONE E C, HUTCHEON M and
LASKIN C Polyarthritis due to Mycobacteriumkansasii in a patient with rheumatoid arthritis:case report, 90
DENMAN A M see HOLLINGWORTH P and DENMAN A MDermatomyositis
muscle biopsy, 500and polymyositis, histological and morphometric
studies, 186, PDeveloping countries, aid for: viewpoint, 411Dextran sulphate induced arthritis, rabbits, 387DICK W C see BALOGH Z et al
HUNTER J A et alDIEPPE P A, SWANN A, HORNBY J, JENKINS R, LUCKMAN
N P and PREECE A W Crystal surface charge andinflammation 605 P
see also ALEXANDER G J M et alDOYLE D V et alMARTIN M et alMARTIN M F R et al
Diffusivity, small solute, synovial fluids facilitate, 580Disabled Living Foundation catalogue, 412DIXON J S, PICKUP M E, LOWE J R, HALLETT C, LEE M R
and WRIGHT V Discriminatory indices of responseof patients with rheumatoid arthritis treated withD-penicillamine 301
see also BInD H A et alDNA synthesis in human rheumatoid and nonrheuma-
toid synovial lining, 241DOLLERY C see BERNSTEIN R et alDOYLE D V, SCOTT J, DEPPE P A and HUSKISSON E C
An articular index for the assessment of osteo-arthritis 606P
see also MINCHINTON R M et alTHROWER PA et al
DOWD P see MARTIN M et alDREW S I, CARTER B M, NATHANSON D S and TERASAKI
P I Levamisole-associated neutropenia andautoimmune granuocytotoxins 59
Drugs, living in an age ofdrugs: viewpoint, 198DUANCE V C see BLACK C M et alDuBowrrz V see BLACK C M et alDUNLOP J see BALOGH Z et alDUNSCOMBE P B and RAMSEYNW Radioactivity studies
on 2 synovial specimens after radiation synovec-tomy with yttrium-90 silicate, 87: correspondence,614
DUQUESNOY B, SANTORO F, WATTRE P, and DELCAMBREB Failure to find Clq-binding material and anti-IgG antibodies in ankylosing spondylitis 449
EASTMOND C J, RAJAH S M, TOVEY D and WRIGHT VSeronegative pauciarticular arthritis and HLAB27 231
WILLSHAW H E, BURGESS S E P, SHINEBAUM R,COOKE E M and WRIGHT V Frequency of faecalKlebsiella aerogenes in patients with ankylosingspondylitis and controls with respect to individualfeatures of the disease 118
EBRINGER A, AVAKIAN H, COWLING P, WELSH J, WOOLEYP, PANAYI G, EBRINGER R and ENTWISTLE CAnkylosing spondylitis, HLA B27, and klebsiella.Cross reactivity studies with rabbit anti-lymphocytesera and human tissue typing sera 194 P
see also COWLING P et alEBRINGER R see COWLING P et al
EBRINGER A et alEDWARDS J C W Relationship between pressure and
digital vasculitis in rheumatoid disease 138EDWARDS J H, PITCHER D, GABELL A, HARVEY W and
GRAHAME R A clinical and echocardiographicstudy of patients with the hypermobility syndrome188P
EDWARDS JM B see VENABLES P JW et atEGHTEDARI A A, BACON P A, and COLLINS A Immuno-
blasts in synovial fluid and blood in the rheumaticdiseases 318
EGIDO J, CREsPo M S, LAHOZ C, GARCiA R, LOPEZ-TRASCASA M and HERNANDO L Evidence of animmediate hypersensitivity mechanism in systemiclupus erythematosus 312
EK S see ROSENTHAL L et alEL-GHOBAREY A F see BALOGH Z et alELIAKIM M see LEvo Y et alELKON K B, BYWATERS E G L, INMAN R Q and HUGHES
G R V Adult onset Still's disease: long-termfollow-up and immunologic studies 187P
see also RYAN P E J et alELLING H, SKINH0J P and ELLING P Hepatitis B virus
and polymyalgia rheumatica: a search for HBaSg,HBsAb, HBcAb, HBeAg, and HBeAb 511
ELLING P see ELLiNG H et alELSON C I see ALLEN C et al
JONES V E et alENGLAND J see PEASE P et alENGLISH J see REEBACK J S et alENTWISTLE C see EBRINGER A et alErosive spondylopathy, 462Erythrocyte sedimentation rate
C-reactive protein and klebsiella in ankylosing spondy-litis, 45
and serum acute phase proteins, effect of ICI 55 897 inrheumatoid arthritis, 18
European Rheumatoid Arthritis Surgical Society, 412EVANS S J W see WOODLAND J et alEYANSON S, PASSo M H, ALDO-BENSON M A and BENSON
M D Methylprednisone pulse therapy for non-renal lupus erythematosus 377
FALLET G H see COURTOIS C et alFALUS A see BALOGH Z et alFELL G S see BALOGH Z et alFELTKAMP T EW see SMN:T J W et al
Index 621
FELTKAMP-VROOM T M see SMIT JW et alFelty's syndrome
is neutrophil surface-bound immunoglobulin a feature,597 P
Femoral head cartilage, composition, 514Fenclofenac, antirheumatic activity, 473FerritinRE cell dysfunction, and systemic rheumatoid arthritis,
597 Psynovial fluid, in rheumatoid arthritis, 596P
Ferrography, a new approach to particles in joint fluid,606 P
Fibronectin in synovium in osteoarthritis and rheumatoidarthritis, 597P
FINEGOLD S M see BROOK I et alFIRTH S A see CLAGUE R B et alFIsCHEL B see WEISS S et alFONG J KK see INMAN R D et alFORD P M see KEANW F et alFORD-HUTCHINSON AW see BERRY H et alFORSTER P J G see MCCONKEY B et alFRANCOIS P E see GOLDBERG I J L et alFRANK A 0 Apparent predisposition to systemic lupus
erythematosus in Chinese patients in WestMalaysia 266
FREI P C see PECOUD A et al
GABELL A see EDWARDS JH et alGALVIN S see SNAITH M et alGARCiA R see EGIDO J et alGEARY M S see HILLS E A and GEARY M SGENTI G, BALINT G, and BORBAS, E Visual analogue
graphy and selective biopsy in 124GIBSON T, HIGHTON J, POTTER C, and SIMMoNDs H A
Renal impairment and gout 417RODGERS V A, POTTER C F, and SImMoNDs H A
Tienilic acid: a single treatment for hyperuricaemiaand hypertension 373
SIMMONDS H A, POTTER C and ROGERS V Allopurinoltreatment and renal function in gout 188 P
see also GRIFFIN A J et alHIGHTON J et alREEBACK J S et alWOJTULEWSKI J A et al
GIL A see ARNALICH F et alGILLIES H G see STEINBERG J et alGIORDANO M Thrombocytosis in giant cell arteritis:
correspondence 298GLADMAN D D, and UROWITZ M B Venous syndromes
and pulmonary embolism in systemic lupuserythematosus 340
Goldbinding to blood cells: correspondence, 529and serum proteins during chrysotherapy, 31
in erythrocytes, whole blood, and plasma during long-term chrysotherapy, 576
induced post-injection reactions in RA, 608 Pand penicillamine: correspondence, 98
peripheral blood lymphocyte responsiveness to Con-Aand pokeweed mitogen in RA, 603 P
in psoriatic arthropathy, 279relationship to diffuse interstitial lung disease, 607 Psalt, betamethasone and aspirin, comparison of effectson chemotaxis of neutrophils, measured in vitro, 25
and thiomalate parts of aurothiomalate, fate afterintramuscular administration, 155
GOLDBERG I J L, LAWTON K, REDDING J H, and FRANCOISP E Gold binding to blood cells 530
GOLDIE I F see ALTHOFF B and GOLDIE I FGOLDSMITH C see OWSIANIKWD J et alGOLDSTONE A H see MCVERRY B A et al
PARRYH F et alGonorrhoea, aseptic arthritis, 141GOTTLIEB N L Gold binding to blood cells: corres-
pondence 529Gout
acute, during hypouricaemic therapy: prophylaxisduring colchicine: correspondence, 529
and amyloidosis, 589attacks, acute, resolution, possible mechanism, 189 Pfrequency of chondrocalcinosis of knees and avascular
studies, 424Gow P J see WOJTULEWSKI J A et alGRAHAME R see EDWARDS J H et al
WOJTULEWSKI J A et alGranulocytopenia, cell mediated autoimmune, in Felty's
syndrome: case report, 399Granulocytotoxins, autoimmune, and levamisole-associ-
ated neutropenia, 59GREEN F A see COSTELLO P B et alGRENNAN D M see DE SILVA R T D et alGRIFFIN A J, HUSTON G, TAYLOR A and GIBSON T
Maintenance chrysotherapy in rheumatoid disease.Comparison of 2 dose schedules 195 P
GRIFFIN J see HIGHTON J et alGRIFFITHS I D see AKYOL S et alGRISCELLI C see TRUNG PH et alGuLDALG see JELLUM E et alGUMPEL J M Radiation synovectomy with yttrium-90
silicate: correspondence 614MATTHEWS S A, ALTMAN D G, SPENCER J D andWILKINS E A An objective assessment of synovitisof the knee: measurement of the size of the supra-patellar pouch on xeroradiography 359
HAAs E DE seeDE HAAS EHABER P see SCHERAK0 et alHADLER N M Synovial fluids facilitate small solute
HALL N D, WINRow VR and BACON P A Lymphocytesbearing Fc receptors in rheumatoid arthritis. I. Anincreased subpopulation of cells in rheumatoidarthritis detected with Facb rosettes 554
see also MORGAN J E et alHALLETT C see DILXON J S et alHALSEY J P, REEBACK J S, CARGILL A F and BARNES C G
A decade of musculoskeletal tuberculosis (1969-78) 596P
HAMILTON ED B see BERRY H et alHANKA R see LEWIS P et alHANLON S M, PANAYI G S and LAURENT R Defective
polymorphonuclear leucocyte chemotaxis in rheu-matoid arthritis associated with a serum inhibitor68
HARLAND S see BERNSTEIN R et alHART F D Viewpoint: Why take up rheumatology? 97HART H and NORVAL M Search for viruses in rheu-
HARvEYW see EDWARDS J H et alHAWKINS C For every ill a pill: Viewpoint 198HAWKINS C F see ScoTTD L et alHAWORTH R J see MOWATA G et alHAY F C see PARRY H F et alHAZLEMAN B L see DE SILVA M and HAZLEMAN B L
LEWIS P et alHEARN P R and RUSSELL R G G Formation of calcium
HEBERDEN SOCIETYAnnual General Meeting and Oration LondonNovember 1979 proceedings, 186
Clinical Meeting, June 1980, London, proceedings, 595Oration 1979: Human aberrations of purine metabo-
lism and their significance for rheumatology, 103speech delivered by Rt. Hon. Patrick Jenkin, 101
HENDERSON B, JOHNSTONE J J and CHAYEN J 5' Nucleoti-dase activity in the human synovial lining inrheumatoid arthritis 248
see also COULTON L A et alHENSiNGER R N, see HUNTER L H and HENSINGER R NHepatitis B virus and polymyalgia rheumatica, 511Hepatotoxicity associated with use of D-penicillamine in
rheumatoid arthritis, 152HERNANDO L see EGIDO J et alHEYWOOD D see BERRY H et alHIGHTON J and PANAYI G S Spontaneous cytotoxicity of
rheumatoid and normal peripheral blood mono-nuclear cells against 4 human lymphoblastoid celllines 559
SHEPHERD P, GRBHEN J and GIoBN T Improvement- in peripheral blood lymphocyte responsiveness to
concanavalin-A and pokeweed mitogen in patientswith rheumatoid arthritis during gold therapy603 P
see GMSON T et alHmLLS E A and GEARYM S Pulmonary capillary volume
(Vc) in rheumatoid disease 187PHILTON R C, BALL J and BENN R T Annular tears in the
dorsolumbar spine 533
HLAantigens in Behcet's disease, comparison of Turkishand British patients, 344
B27 klebsiella and ankylosing spondylitis, cross reac-tivity studies, 194P
and pauciarticular arthritis, seronegative, 231-positive juvenile arthritis, aortic incompetence in:
case report, 294Yersinia enterocolitica and ankylosing spondylitis:correspondence, 415
HOBBS J R see WEBLEY M et alHOFNER W see SCHERAK 0 et alHOLBOROW E J see BROWN K A et al
JOHNSON G D et alJOHNSON G D and HOLBOROW E JOSUNG 0 A et al
HOLLINGS E M see MOWAT A G et alHOLLINGWORTH P and DENMAN A M The effect of
therapy for connective tissue disorders on viruslymphocyte interactions 189P
REARDON J A, and SCOTT J T: Acute gout duringhypouricaemic therapy: prophylaxis with colchi-cine: correspondence, 529
see also LISTER PD and HOLLINGWORTH PHOLMES K see CHRISTIANSEN K et alHOLT P J L see BEALES J G et al
CLAGUE R B et alMORGAN K et alRAJAPAKSE C N A et al
HORNBY J see DIEPPE P A et alHORSFALL A, VENABLES P J W, MUMFORD P and MAINI
R N A fallacy in the interpretation of the Raji cellassay for immune complexes 193 P
HORSFALL A C, see MUMFORD P A et alHUBSCHER 0 see SCHEINBERG M A et alHUFFSTADT A J C see RASKER J J et alHUGHES G R V see BECKER G J et al
BERNSTEIN R et alBLACK C M et alCAEIRO F et alCAMBRIDGE G et alELKON K B et alINMAN R D et alRYAN P E J et alSEWELL J R et al
HUNTER J A, MILLS G, DICK W C and STURROCK R DFerrography: a new approach to particles in jointfluid 606P
see also CAPELLHA et alHUNTER L Y and HENSINGER R N Destructive arthritis
associated with acne fulminans: case report, 403HURSTN and NUKi G Monocyte function in rheumatoid
arthritis: evidence for a defect in immune phago-cytosis in patients with vasculitis 599P
HUSBY G see WILLKENS R F et alHUSKISSON E C see DOYLED V et al
THRowER PA et alHUSTON G see GRIFFIN A J et alHUTCHEON M see DEMERIEUX P et alHUTCHINSON AW FoRD- see FORD-HUTCHINSON AWHydrallazine lupus, 194P
Index 623
Hydroxyproline fractions in RA and nonautoimmunearthropathies, 207
Hyperlipidaemia and arthropathy, association withconnective diseases, 490
Hypersensitivity mechanism in SLE, 312Hypertension and gout, tienilic acid treatment, controlled
inpatient study, 367, 373Hyperuricaemia and hypertension, tienilic acid treatment,
373Hypermobility syndrome, clinical and echocardiographic
Immune complexesand anti-IgG antibodies in ankylosing spondylitis,
failure to find, 449assays in RA and SLE, different profiles, 602 PRaji cell, fallacy in interpretation, 193 P fcontaining both IgM and IgG rheumatoid factors,
600 Pcirculating, in ankylosing spondylitis, 445and intra-articular, in rheumatoid arthritis, 438
Immunity, cellular, to possible synovial antigens inrheumatoid arthritis, 539
Immunoblasts in synovial fluid and blood in rheumaticdiseases, 318
ImmunoglobulinsA, serum, raised, association with inflammation in
ankylosing spondylitis, 545G antiglobulins in RA and other arthritides, 191 PM and G antibodies to native type II collagen in native
type II collagen-induced disease, significance,192 P
low molecular weight, quantitation and evaluation inrheumatoid arthritis, 349
with IgG and cell nuclear antigen, 586complement fixing, hidden, lack in adult seronega-
tive rheumatoid arthritis, 64Immunoreactive prolyl hydroxylase, serum, in inflam-
matory rheumatic diseases, 217Infectious mononucleosis, antibodies to RANA and
other nuclear antigens in, 191 PInflammation
association with raised serum IgA in ankylosingspondylitis, 545
and crystal surface charge, 605PINMAN R D, FONG J3K K, PUSSEL B A and HuGHEs G R V
The Clq binding assay in SLE: discordance withdisease activity 193P
INMAN R Q see ELKoN K B et atInternational Congress of Rheumatology, 15th, June
1981, Paris, announcement, 615Iron deficiency, true, diagnosis in rheumatoid arthritis,
595 PIsHLI M see COWLING P et at
JACOBY R K Effect of homologous synovial membraneon adult human articular cartilage in organculture, and failure to influence it with D-penicilla-mine 53
JAMESDW see BERRY H et alJAMES 0 see AKYOL S et alJAYSON M I V The scope of rheumatology: viewpoint,
528JELLUM E, MuNTHE E, GULDAL G and AASETH J Fate of
the gold and the thiomalate part after intramuscu-lar administration of autothiomalate to mice 155
JENKIN P Front line role 101JENKINS R see DIEPPE P A et alJOHNSON G D, CARVALHO A, HOLBOROW E J and
RUSSELL, G Antiperinuclear factor and keratinantibodies in RA 599 P
and HOLBOROW E J Standardisation of tests for anti-nuclear antibody: correspondence 529
JOHNSON PM Apparent cross-reactions of IgM-rheuma-toid factors and their implication 192P
IgM-rheumatoid factors cross-reactive with IgG and acell nuclear antigen: immunopathological implica-tions 586
JOHNSTONE J J see HENDERSON B et alJoints
affected, in juvenile chronic arthritis, fantasies aboutappearance 602 P
beautifully engineered: viewpoint, 296fluid, particles in, ferrography, 606P
JONES H see ALEXANDER G J M et alJONES H E see MARTIN M F R et alJONES V E, COWLEY P J, ALLEN C, and ELSON C J The
isolation of immune complexes containing bothIgM and IgG rheumatoid factors 600P
Joos A see ABRAHAm A A and Joos AJUBB R W The effect of synovium on proteoglycan syn-
thesis by human articular cartilage 196PJuvenile chronic arthritis
fantasies about appearance of affected joints amongchildren, 602P
neutrophil chemotaxis, 481serological abnormalities, review of 46 cases, 129seropositive, aortic regurgitation in, 607PHLA B27-positive, aortic incompetence in: case report,294
K andNK cell activity ofhuman blood: differences accord-ing to sex, age, and disease, 82
KAPLAN S B see ROTHSCHILD B M et alKATZ WA see ROSENBAUM I et alKEAN W F, ANASTASSIADES T P and FoRD P M Aortic
incompetence in HLA B27-positive juvenile arthritis:case report, 294
KEAT A C, THOMAS B J, TAYLOR-RoBINSON D, PEGRUMG D, MAINI R N, and Scorr J T Evidence ofChlamydia trachomatis infection in sexuallyacquired reactive arthritis 431
KEEN J H see BEALES JGet alKENNEDYA C see COSTELLO P B et alKeratin antibodies and antiperinuclear factor in RA, 596
PKEYSTONE E C see DEMERTEUX P et at
624 Index
KINSELLA P see CROKER J R eta!RICHTER M B et al
KIRBY J see MARTIN M et alKISCH E S see WEISS S et alKIVIRKKo K I see KUU1TI-SAVOLAINEN E-R et alKlebsiella
association with ankylosing spondylitis, 606PC-reactive protein and ESR in ankylosing spondylitis, 45faecal carriage by patients with ankylosing spondylitisand rheumatoid arthritis, 37, 118
HLA B27, and ankylosing spondylitis, cross reactivitystudies, 194P
Klebsiella aerogenes, faecal, in ankylosing spondylitis,frequency, 118
Kneeschondrocalcinosis, and avascular necrosis of femoral
heads in gout, frequency, 7joint and popliteal bursae, communication between,
anatomy and function, 354synovitis, objective assessment, 359
KOLARZ G see SCHERAK 0 et alKRAAG G R see OWSIANIKWD J et alKUMMER F see ScHERAK 0 et alKUNDI A see OWSIANIK W D J et alKuurrI-SAVOLAINEN E-R, KIVIRIKKO K I and LAITINEN 0
LAFEBER G JM see MEIER C J L M et alLAHoz C see EGIDO J et alLAITINEN 0 see KuuTri-SAvOLAINEN E-R et alLASKIN C see DEMERIEUX P et alLAURENT R see HANLON S M et alLAWTON K see GOLDBERG I J L et alLEAK A M, MILLAR-CRAIG M, and ANSELL B M Aortic
regurgitation in seropositive juvenile arthritis 607PLecturing types, classification derived from a detailed
analysis of scientific communications, 193 PLEEM R see BIRD H A et al
DIXON J S et alLEEK J C and ROBBINS D L Haemophilus influenzae
tenosynovitis: correspondence, 530LEIMGRUBER A see PECOUD A et alLeucocytes
migration, nonspecific inhibitory effect of synovialtissue extracts on, 323
movement, inhibitor in rheumatoid arthritis plasma,563
polymorphonuclear, see Polymorphonuclear leucocytesLeucocytoclastic angiitis, associated with arthritis: case
report, 526Levamisole-associated neutropenia and autoimmune granulo-
cyotoxins, 59low-dose (150 mg/week), as alternative to gold in RA,
602 PLEVINSON D J and SORENSEN L B Renal handling of uric
acid in normal and gouty subjects: evidence for a4-component system 173
see also SORENSEN L B and LEVINSON D JLEVO Y, SHALEv 0, ROSENMANN E, and ELIAKIMM Gout
and amyloidosis 589
LEWIS P, HAZLEMAN B L, HANKA R, and ROBERTS SCause of death in patients with rheumatoid arthri-tis with particular reference to azathioprine 457
LIANG M H see SLAVIN S and LIANG M HLIEBERMAN D H see ROSENBAUM J et alLimb oedema, cause by lymphatic obstruction in rheuma-
toid arthritis, 260LISTER P D and HOLLINGWORTH P Arthritis associated
with leucocytoclastic angiitis: case report, 526LOCKWOOD C M see WILLIAMS B D et alLoPEz-TRAsCASA M, see EGIDO J et alLow back pain research, Volvo awards, 412LOWE J R see DIXON J S et alLUCKMAN N P see DIEPPE P A et alLUDIVICO C L and MYERS A R Survey of synovial fluid
cryoprecipitates 253Lung disease, diffuse interstitial, relationship to gold and
penicillamine therapy, 607PLupus erythematosus
nonrenal, methylprednisone pulse therapy for, 377systemic, active nonrenal, reticuloendothelial function,
191 PANA-negative, serological findings, 600Papparent predisposition in Chinese patients in West
Malaysia, 266in childhood, 601 Pcomplement, (C3) activation, 601 PClq binding assay in, discordance with disease
activity, 193Pimmediate hypersensitivity mechanism in, 312plasma exchange in, 195 Ppulmonary involvement: correspondence, 297, 414and RA, immune complexes, different profiles, 602Preduced prostacyclin activity in, 524serum C-reactive protein measurement in investiga-
tion of fever, 50tendon rupture in: case report, 592venous syndromes and pulmonary embolism in, 340
Lupus, hydrallazine, 194 PLymph nodes in rheumatoid arthritis and malignant
lymphoma, immunocytological studies, 147Lymphadenopathy, angioimmunoblastic, associated with
polyarthritis: case report, 406Lymphatic obstruction in rheumatoid arthritis causing
cytotoxicity of rheumatoid and normal peripheralblood mononuclear cells against, 559
Lymphocytesbearing Fc receptors in rheumatoid arthritis. I. An
increased subpopulation of cells in rheumatoidarthritis detected with Facb rosettes, 554
electrophoretically characterised subpopulationincreased in, 190P
membrane and transformation characteristics oflymphocytes, 75
peripheral blood, responsiveness to con-A and poke-weed mitogen during gold therapy in RA, 603 P
T, subpopulations in ankylosing spondylitis, 566virus interactions, effect of therapy for connective tissue
disorders on, 189P
Index 625
Lymphoma, malignant, and rheumatoid arthritis, lymphnodes in, immunocytological studies, 147
Lymphopenia, T, in acute anterior uveitis and ankylosingspondylitis, 190P
MACHIN S J see McVERRY B A et alMACINTOSH P see PEASE P et alMCCLUSKEY R T see COSTELLO P B et alMCCONKEY B, AMOS R S, BILLINGHAM M E J, CONSTABLE
T J, CROCKSON R A, CROCKSON A P and FORSTERP J G Rheumatoid arthritis: effects of a new agent(ICI 55 897) on serum acute phase proteins and theerythrocyte sedimentation rate 18
MACKAY I R see PENSCHOW J and MACKAY I RMACKLON A F see AKYOL S et alMCVERRY B A, MACHIN S J, PARRY H, and GOLDSTONE
A H Reduced prostacyclin activity in systemiclupus erythematosus 524
MADDISON P J, PROVOST T T, and REICHLINM Serologi-cal findings in patients with 'ANA-negative' SLE600 P
MAINI R N see BoURKE B et alHORSFALL A et alKEAT A C etalMUMFORD P A et alVENABLES P JW et al
MANICOURT D, BRAUMAN H and ORLOFF S Synovialfluid B, microglobulin and hydroxyprolinefractions in rheumatoid arthritis and nonautoim-mune arthropathies 207
MANTM J see ROTHWELL R S et alMARKS J S and SHARP J Rheumatoid cervical myelo-
pathy 607PMARKS V see REEBACK J S et alMAROUDAS A, BAYLISS M T, and VENN M F Further
studies on the composition of human femoral headcartilage 514
MARTnIN M, DowD P, RING F, DIEPPE P and KIRBY JProstaglandin E1 (PGE1) in the treatment ofsystemic sclerosis (SS) 194P
MARTIN M F R, DIEPPE P A, JoNS H E, WARREN C andWHICHER J Serum concanavalin-A binding inrheumatoid arthritis 597P
MASON J see WOJTULEWSKI J A et alMATTHEWS S A see GUMPEL J M et alMEACHM G and PEDLEY R B Implications of a sex
difference in osteoarthrosis: correspondence, 199Meetings, really effective, planning and content: view-
point, 410MEIJER C J L M, VAN DE PuTrE L B A, LAFEBER G J M,
DE HAAs E and CATS A membrane and transfor-mation characteristics of lymphocytes isolatedfrom the synovial membrane and paired peripheralblood of patients with rheumatoid arthritis 75
MELLOR V P see BEALES JG et alMERiTEYKsee BALOGH Z et alMetal sensitivity causing loosened joint prostheses, 476Methylprednisone pulse therapy for nonrenal lupus
erythematosus, 377MICHILSON F see CAEIRo F et alMicroglobulin, Bl, plasma levels, rheumatoid arthritis,
333
Microglobulin, B2, synovial fluid, in RA and nonautoim-mune arthropathies, 207
MILAZZO S C see ROBERTS-THOMSON P J et alMILLAR-CRAIG M see LEAK A M et alMILLS G see HUNTER J A et alMINCHINTON R M, DOYLE D V, and WATERS A H
Neutrophil surface-bound immunoglobulin-afeature of Felty's syndrome 600P
MINNS R J and STEVEN F S Local denaturation ofcollagen fibres during the mechanical rupture ofcollagenous fibrous tissue 164
MOLL J M H see WRIGHT V andMoLL J M HMOLLOYM G see BERRYH et alMonocyte function in rheumatoid arthritis, 599 PMononuclear cells, peripheral blood, rheumatoid and
normal, spontaneous cytotoxicity against 4 humanlymphoblastoid cell lines, 559
MOORE T L see ROBBINS D L and MOORE T LMORAN C J see PARRYH F et alMoraxella infectious arthritis, first report in adult: case
report, 184MORGAN J E, HALL N D, COLLINS A J, and BACON P A
The nonspecific inhibitory effect of synovial tissueextracts on leucocyte migration in vitro 323
MORGAN K, CLAGUE R B, SHAW M J and HOLT P J LNative type II collagen-induced arthritis in the rat.I. Incidence and humoral response to collagen 285
Significance ofIgM and IgG antibodies to nativetype II collagen in native type II collagen-induced disease 192P
see also CLAGUE RB et alMORROWW JW see PARRY H F et alMORTEO 0 G see SCHEINBERG M A et a!Moss I see BOURKE B et alMOWAT A G, NICHOLS P J R, HOLLINGS E M, HAWORTH
R J and AITKEN L C A comparison of follow-upregimes in rheumatoid arthritis 12
MUFTUOGLU M see YAZICI H et alMUIRDEN K D, see ROBINSON A D and MUIRDEN K DMUMFORD P see HORSFALL A et alMUMFORD P A, HORSFALL A C and MMM R N The
different profiles of immune complex assays inRA and SLE 602P
MUNTHE E see JELLUM E et alMURDOCH RM see CAPELL H A et alMuscle biopsy in polymyositis and dermatomyositis, 500Musculoskeletal tuberculosis, decade of (1969-1978)
596 PMycobacteriumn kansasii, polyarthritis due to, in patient
with rheumatoid arthritis: case report, 90Mycocytotoxicity assay, lymphocytes from polymyositis/
dermatomyositis patients, 190PMyelopathy, rheumatoid cervical, 607 PMYERS A R see LUDIVIco C L and MYERS A R
Nailfold vasculitis in rheumatoid disease, 138NATHANSON D S see DREW S I et alNEILL W A Cell-mediated cytotoxicity for cultured
autologous rheumatoid synovial membrane cells570
NEOH S H see ROBERTS-THOMSON P J et a!
626 Index
Neutropenia, levamisole-associated, and autoimmunegranulocytotoxins, 59
Neutrophilschemotaxis, comparison of effects of gold salt, beta-
methasone and aspirin, measured in vitro, 25in juvenile chronic arthritis, 481
surface-bound immunoglobulin-feature of Felty'ssyndrome, 600 P
NEWMAN J H see COONEY L M et alNICHOLS, Philip John Russell, obituary, 298
see also MOWAT A G et alNIENHUIS R L F see RASKER J J et alNILSSON E and BIBERFELD G Subpopulations of T
lymphocytes in patients with ankylosing spondyli-tis 566
NINEHAM L J see PARRY H F et alNK and K cell activity of human blood: differences
according to sex, age, and disease, 82NOBLE J, STEINBERG J, SLEDGE C B and STIRRAT C R A
tissue culture model for cartilage synoviuminteraction 196P
see also STEINBERG J et alNORVAL M see HART H and NORVAL M5'Nucleotidase activity in human synovial lining in
rheumatoid arthritis, 248NUKI G see HURSTN and NUKI G
OBITUARY, Philip John Russell Nichols, 298OCHI T, YONEMASU K and ONO K Immunochemical
quantitation of complement components of Clqand C3 in sera and synovial fluids of patients withbone and joint diseases 235
O'DRISCOLL S and O'DRISCOLL M Osteomalacia inrheumatoid arthritis 1
see also O'DRISCOLL M and O'DRISCOLL SOgryzlo International Fellowship, second, announce-,
ment, 412OLHAGEN B see ROSENTHAL L et alONO K see OCHI T et alORLOFF S see MANICOURT D et alOsteoarthritis
articular index for assessment, 606Pfibronectin in synovium, 597 Pas a mechanical, noninflammatory 'wear and tear'
condition: correspondence, 200implications of a sex difference: correspondence, 199
Osteomalacia in rheumatoid arthritis, 1OSUNG 0 A, CHANDRA M and HOLBOROW E J Antibody
against 10 nm filaments in rheumatoid arthritis598 P
OWSIANIK W D J, KUNDI A, WHITEHEADJ N, KRAAG G Rand GOLDSMITH C Radiological articular involve-ment in the dominant hand in rheumatoid arthritis508
case report, 406due to M. kansasii in patient with rheumatoid arthritis:
case report, 90seronegative chronic, clinical and serological correlates,
550Polymorphonuclear leucocytes, defective chemotaxis, in
rheumatoid arthritis associated with serum inhibitor,68
Polymyalgia rheumatica and Hepatitis B virus, 511collagen changes, 186Pand dermatomyositis, histological and morphometric
studies, 186Pmuscle biopsy, 500
Popliteal bursae and knee joint, communication between,anatomy and function, 354
POTTER C see GIBSON T et alPOTTER C F see GIBSON T et alPrednisolone acetate, plasma steroid levels after intra-
articular injection in rheumatoid arthritis, 22PREECE AW see DIEPPE P A et alPRIEuR A M see TRUNG PH et alProceedings Heberden SocietyAnnual General Meeting and Oration, November 1979,London, 186
Clinical Meeting, June 1980, London, 595Prostacyclin activity, reduced in systemic lupus erythema-
tosus, 524Prostaglandin E1 in treatment of systemic sclerosis, 194PProstheses, joint, loosening caused by metal sensitivity,
476Proteins, acute phase, see Acute phase proteinsPROVOST T T see MADDISON P J et alPseudogout, formation ofcalcium pyrophosphate crystals
in vitro, 222Psoriatic
arthritis, incidence of serum antibodies to native typesI and II collagens in, 201
arthropathy, gold in, 279PUIG J G see ARNALICH F et alPulmonary
capillary volume in rheumatoid arthritis, 187 Pembolism and venous syndromes in SLE, 340involvement in SLE: correspondence, 297manifestation in systemic lupus erythematosus:
correspondence, 414Purine metabolism, aberrations, significance for rheuma-
tology: Heberden oration 1979, 103PUSSEL B A see INMAN RD et alPUSSELL B A see WILLIAMS BD et alPurE L B A VAN DE see VAN DE PuTrE L B APyrophosphate arthropathy-a clinical study, 606 P
Radiation synovectomy with yttrium-90 silicate 87:correspondence, 614
RAJAH S M see EASTMOND C J et al
RAJAPAKSE C N A, HOLT P J L and PERERA B S Diagno-sis of true iron deficiency in rheumatoid arthritis595 P
Raji cell assay for immune complexes, fallacy in interpre-tation, 193
RAMSEYNW see DUNSCOMBE P B and RAMSEY NWRASKER J J, VELDHUIS E F M, HUFFSTADT A J C and
NIEEHUIS R L F Excision of the ulnar head inpatients with rheumatoid arthritis 270
RASKER J L, DAVIS P, and BACON P A: Seronegativechronic polyarthritis: clinical and serologicalcorrelates 550
RAUSCHNINGW Anatomy and function of the comomuni-cation between knee joint and popliteal bursae 354
REARDON J A and ScoTr J T Controlled inpatient studyof tienilic acid in treatment of gout and hyper-tension 367
Resolution of acute gout attacks: a possible mecha-nism 189 P
see HOLLINGWORTH P et alREDDING JH see GOLDBERG I J L et alREEBACK J S, CHAKRABORTY J, ENGLISH J, GIBSON T and
MARKS V Plasma steroid levels after intra-articularinjection of prednisolone acetate in patients withrheumatoid arthritis 22
see HALSEY J P et alREICHLIN M see MADDISON P J et alRenal
disease, chronic, gout secondary to, urate metabolismstudies, 424
function in gout, and allopurinol treatment, 188 Phandling of uric acid in normal and gouty subjects,
evidence for a 4-component system, 173impairment in gout, 417
Reticuloendothelial functionin active nonrenal SLE, 191 Pferritin and rheumatoid arthritis, 597P
REZA M J see BROOK I et alRheumatic disease, treatment, 2nd International Sym-
posium, Israel, November 1980, announcement,412
Rheumatoid arthritisalclofenac and D-penicillamine, biochemical com-
37antibody against 10 nm filaments in, 598 Pantibodies, to RANA and other nuclear antigens, 191 Pserum, to native types I and II collagens, incidence,
201antiperinuclear factor and keratin antibodies in, 599 Pazathioprine in, double blind study, 604 PB2 microglobulins, and hydroxyproline fractions,
synovial, 207plasma levels, 333
chrysotherapy, maintenance, comparison of 2 doseschedules, 195P
clinical assessments of disease activity, comparison, 135cause of death in, reference to azathioprine, 457cellular immunity to possible synovial antigens in, 539clotrimazole in, 469
population increased in, 190Pferritin, synovial fluid, 596 P, 597Pfibronectin in synovium, 597Pfollow-up regimes, comparison, 12gold induced post-injection reactions, 608 Phepatotoxicity associated with use of D-penicillamine,
152(ICI 55 897) effects of new agent on serum acute phase
proteins and ESR, 18immune complexes in, 438immunoglobulin G antiglobulins in, 191 PIgM and lgG, isolation of immune complexes contain-
ing both, 600 Piron deficiency in, diagnosis, 595 Plow-dose levamisole as alternative to gold, 602 Plymphatic obstruction causing limb oedema, 260lymphocytes bearing Fc receptors in. I. An increased
subpopulation of cells in rheumatoid arthritisdetected with Facb rosettes, 554
and malignant lymphoma, lymph nodes in, immuno-cytological studies, 147
membrane and transformation characteristics oflymphocytes, 75
monocyte function, 599Pnuclear antigen, and other nuclear antigens, antibodies
to in infectious mononucleosis and rheumatoidarthritis, 191 P
osteomalacia in, ID-penicillamine treatment, discriminatory indices of
response, 301peptic ulcer in, use of cimetidine, 275plasma steroid levels after intra-articular injection of
polyarthritis due to M. kansasii in patient with, 90pulmonary capillary volume, 187 Pradiological articular involvement in dominant hand,
508seronegative, adult, lack of hidden complement fixingIgM rheumatoid factor, 64
sulphasalazine in, biochemical study, 603 Psystemic, ferritin and RE cell dysfunction, 597 Pand SLE, immune complexes, different profiles 602 Pthymopoietin for, 604Pulnar head excision in, 270vasculitis, pressure and digital relationship between, 138zinc plasma, relationship to clinical symptoms and
search for viruses in, 159Rheumatoid vasculitis, systemic, clinical spectrum and
prognosis, 595 P
RhWumatology, reasons for taking up: viewpoint, 97scope: viewpoint, 528Spanish postgraduate course February 1981, Barcelona,announcement, 615
RHIND V M, BIRD H A and WRIGHT V A comparison ofclinical assessments of disease activity in rheuma-toid arthritis 135
RICHARDS J D M see PARRY 14 F et atRICHTER M B, KINSELLA P and CORBETT M Gold in
psoriatic arthopathy 279RING F see MARTIN M et alROBBINsD Land MooRET L Lackofhiddencomplement
fixing IgM rheumatoid factor in adult seronegativerheumatoid arthritis 64
see LEEK J C and ROBBINS D LROBERTS S see LEWIS P et alROBERTs-THOMSON P J, NEOH S H and BRADLEY J
Quantitation and evaluation of low molecularweight IgM in rheumatoid arthritis 349and MILAZZO S C Circulating and intra-articularimmune complexes in rheumatoid arthritis: acomparative study of the Clq binding andmonoclonal rheumatoid factor assays 438
ROBINSON A D and MUIRDEN KD Cellular immunity topossible synovial antigens in rheumatoid arthritis539
ROBINSON, D TAYLOR- see TAYLOR-RoBINSON DRODGERS V A see GIBSON T et alROGERS V see GIBSON T et alRoITT I M see PARRY H F et alROSENBAUM J, KATZ W A and SCHUMACHER H R
Hepatotoxicity associated with use of D-penicilla-mine in rheumatoid arthritis 152
LIEBERMAN D H and KATZ W A Moraxella infectiousarthritis: first report in an adult: case report, 184
ROSENMANN E see LEVO Y et alROSENTHAL L, OLHAGEN B and EK S Aseptic arthritis
after gonorrhoea 141RoTH G F see WILLKENS R F et alROTHSCHILD B M, SIENKNECHT C W, KAPLAN S B and
ROTHWELL R S, MANT M J and DAVIS P Angioimmuno-blastic lymphadenopathy associated with poly-arthritis: case report, 406
RuIz DE ANDRES S see ARNALICH F et alRUSSELL R G G see HEARN P R and RUSSELL R G GRYAN P see BERNSTEIN R et alRYAN P E J, ELKON K B, SEWELL J R and HUGHES G R V
A study of reticuloendothelial function (REF) inactive nonrenal SLE 191 P
Sacroiliac disease, value of quantitative scanning, 188 PSANTORO F see DUQUESNOY B et alSATTAR M A see CAWLEYM I D et alSAVOLAINEN E-R KUuTTI- see KUUrrI-SAVOLAINEN E-RSAXNE T see SJOBLOM KG et alSCHEINBERG M A, HUBSCHER 0, MORTEO 0 G and
BENSON M D Serum amyloid protein levels inSouth American children with rheumatoid arthri-tis: a co-operative study 228
Index 629
SCHERAK 0, HOFNER W, HABER P, KUMMER F, KOLARZ Gand SEIDL G Systemic lupus erythematosus andpulmonary manifestations: correspondence, 414
SCHREUDER I see YAZICI H et alSCHUMACHER H R see ROSENBAUM J et alSCHWARZ H A, SLAVIN G and ANSELL B M Histological
and morphometric studies in polymyositis (PM)and dermatomyositis (DM) 186P
WARD P and ANSELL B M Muscle biopsy in poly-myositis and dermatomyositis: a clinicopatholo-gical study, 500
ScoTT D G I, ALLEN C, PAPADMITRIOUS G and BACONP A Effect of immunosuppression on rheumatoidsynovitis and vaculitis 196P
BACON P A and TRIBE C R The clinical spectrum andprognosis of systemic rheumatoid vasculitis 595 P
see ALEXANDER G JM et alALLEN C et al
SCOTT D L, BRADBY G V H, ZAPHIROPOULOS, G C andHAWKINS C F The relationship of diffuse inter-stitial lung disease to gold and penicillaminetherapy 607 P
and WALTON K W Fibronectin in the synovium inosteoarthritis and rheumatoid arthritis 597 P
SCOrr J see DOYLE D V et alTHROWER P A et at
SCOTT J T see DARLINGTON L G et alHOLLINGWORTH P et alKEAT A C et alREARDON J A and SCOTT J TSTOCKMAN A et al
SEEGMILLER J E Human aberrations of purine meta-bolism and their significance for rheumatology:Heberden Oration 1979 103
SEGOVIAD ALARCON- see ALARCON-SEGOVIA DSEIDL G see SCHERAK 0 et alSeptic arthritis, see Arthritis, septicSerological abnormalities in juvenile chronic arthritis,
review of46 cases, 129SEWELL J see WILLIAMS B D et alSEWELL J R, ALLISON D J, TARuN D and HUGHES G R V
Combined temporal arteriography and selectivebiopsy in suspected giant cell arteritis 124
see also CAMBRIDGE G et alRYAN P E J et al
SHALEV 0 see LEVO Y et alSHARP J see MARKS J S and SHARP JSHAW M J see CLAGUE R B et al
MORGAN K et alSHEPHERD P see HIGHTON J et alSHINEBAUM R see EASTMOND C J et alSHORT M see SNAITH M et alSickle cell disease associated with uric acid deposition
disease, 392SIENKNECHT CWsee ROTHSCHILD B M et alSILvA R TDDE seeDE SILvAR TDSIMMONDs H A see GIBSON T et alSJOBLOM K G, SAxNETand WOLLHEIM F A Plasma levels
of B2-microglobulin in rheumatoid arthritis 333SKINH0J P see ELLINGH et alSLACK J see DARLINGTON LG et alSLANEY J see PANAYI G S et al
SLAVIN S and LIANG M H Cell mediated autoimmunegranulocytopenia in a case of Felty's syndrome:case report, 399
see also SCHWARZ H A et alSLEDGE C B see NOBLE J et al
STEINBERG J et alSMIT J W, SONDAG-TSCHROOTS I R J M, AAIJ C, FELT-
KAMP T E W and FELTKAMP-VROOM T M Theantiperinuclear factor: II. A light microscopicaland immunofluorescence study on the antigenicsubstrate 381
SMITH M J H see WALKER J R and SMITH M J HSNAITH M, GALVIN S and SHORT M The value of
quantitative scanning in sacroiliac disease 188 PSNAITH M L see PARRYH F et alSOLOMON L Another look at osteoarthritis: correspon-
dence, 200SONDAG-TSCHROOTS I R J M see SMIT J W et alSORENSON L B Gout secondary to chronic renal disease:
studies on urate metabolism 424and LEVINSON D J Isolated defect in postsecretory
reabsorption of uric acid: case report, 180see also LEVINSON D J and SORENSEN L B
South African Rheumatism and Arthritis Association,7th Biennial Congress, Pretoria, announcement,200
SPAGNUOLO P J Septic arthritis due to Pasteurellamultocida: correspondence, 98
SPENCER J D see GUMPEL JM et alSPINDLER J S see ROTHSCHILD B M et alSpine, dorsolumbar, annular tears, 533Spondylopathy, erosive, 462STADT R J VAN DE see VAN DE STADT R JSTEINBERG J, SLEDGE C B, NOBLE J and GILLIES H G
Dextran sulphate induced in rabbits 387see also NOBLE J et al
STERN C M see CAMBRIDGE G et alSteroids, intra-articular, systemic effects: correspondence,
413plasma levels after intra-articular injection of pre-
dnisolone acetate in rheumatoid arthritis, 22STEVEN F S see MiNNs R J and STEVEN F SSTEWART I M see THEWD CN and STEWART I MStill's disease, adult onset, long-term follow-up and
immunologic studies, 187PSTIRRAT C R see NOBLE J et alSTOCKMAN A, DARLINGTON L G and SCOTT J T Fre-
quency of chondrocalcinosis of the knees andavascular necrosis of the femoral heads in gout: acontrolled study 7
STURROCK RD see HUNTER J A et alSulphasalazine in rheumatoid arthritis, biochemical
study, 603 PSWANNA see DIEPPE P A et alSynovectomy, radiation, with yttrium-90 silicate, radio-
activity studies on 2 synovial specimens, 87:correspondence, 614
Synovialfluid abnormalities in septic arthritis detected by gas-
liquid chromatography, 168antibiotic concentrations after oral administration,
608 P
630 Index
B2 microglobulin and hydroxyproline fractions,RA and nonautoimmune arthropathies, 207
antigens, cellular immunity to, rheumatoid arthritis,539
cryoprecipitates, survey, 253facilitate small solute diffusivity, 580ferritin in rheumatoid arthritis, 596 Pimmunoblasts, in rheumatic diseases, 318macrophages, rheumatoid, search for viruses in, 159and therapeutic arthrocentesis, descriptions in aNahuatl text from prehispanic Mexico, 291
see also Joint fluidmembrane, cells, rheumatoid, cultured autologous,
cell-mediated cytotoxicity for, 570homologous, effect on articular cartilage in organ
culture, failure of D-penicillamine to influence, 53tissue extracts, nonspecific inhibitory effect on leucocyte
migration in vitro, 3235' nucleotidase, rheumatoid arthritis, 248rheumatoid and nonrheumatoid,DNA synthesis, 241
Synovitisknee, objective assessment, 359rheumatoid, and vasculitis, effect of immunosuppres-
sion, 196PSynovium, effect on proteoglycan synthesis by human
articular cartilage, 196 PSystemic sclerosis
progressive, with pancreatic necrosis: case report, 396treated with prostaglandin E1, 194P
TARIN D see SEWELL J R et alTAUTZ I Gold and penicillamine: correspondence, 98TAYLOR A see GRIFFIN A J et alTAYLOR-ROBINSON D see KEAT A C et alTemporal arteriography and selective biopsy, combined,
in suspected giant cell arteritis, 124Tendon rupture in SLE: case report, 592Tenosynovitis, Haemophilus influenzae: correspondence,
530TERASAKI P I see DREW S I et alTHEW D C N and STEWART I M D-penicillamine and
breast enlargement: correspondence, 200THOMAS B J see KEAT A C et alTHOMPSON M see AKYOL S et alTHOMSON, P J ROBERTS- see ROBERTS-THOMSON P JThrombocytosis in giant cell arteritis: correspondence, 298THROWER P A, DOYLE D V, SCOTT J and HUSKISSON E C
Thymopoietin for rheumatoid arthritis 604 PThymopoietin for rheumatoid arthritis, 604PTienilic acid in treatment of gout and hypertension, 367,
373TILSTRA B ABBO- see ABBO-TILSTRA BT-lymphopenia in acute anterior uveitis and ankylosing
spondylitis, 190PTOVEY D see EASTMOND C J et alTRIBE C R see SCOTT D G I et alTRUNG P H, PRIEUR A M and GRISCELLI C Neutrophil
chemotaxis in juvenile chronic arthritis 481TSCHROOTS, J M SONDAG- see SONDAG-TSCHROOTS J MTuberculosis, musculoskeletal, decade of (1969-1978),
596 P
TWOSE T see CLAGUE R B et alTYLER R see PEASE P et al
Ulnar head excision in rheumatoid arthritis, 270Urate metabolism studies in gout secondary to chronic
renal failure, 424Uric acid
deposition disease associated with sickle cell disease,392
renal handling in normal and gouty subjects, evidencefor a 4-component system, 173
isolated defect in postsecretory reabsorption: casereport, 180
UROWITZ M B see GLADMAN D D and UROWITZ M BUveitis, acute anterior, T-lymphopenia in, 190P
VALENTE A J and WALTON K W Studies on increasedvascular permeability in the pathogenesis oflesions of connective tissue diseases, I. Experi-mental hyperlipidaemia and immune arthropathy490
VAN DE PUTTE L B A see MEIJER C J L M et alVAN DE STADT R J and ABBO-TILSTRA B Gold binding to
blood cells and serum proteins during chryso-therapy 31
Vasculitisevidence for defect in immune phagocytosis in, 599 Ppressure and digital, relationship between, in rheuma-
toid disease, 138and rheumatoid synovitis, effect of immunosuppression
196 PVAZQUEZ J J see ARNALICH F et alVELDHUIS E F M see RASKER J J et alVENABLES P J W, MAINI R N and EDWARDS J M B
Antibodies to RANA and other nuclear antigens ininfectious mononucleosis (IM) and rheumatoidarthritis (RA) 191 P
see also HORSFALL A et alVENN M F see MAROUDAS A et alVenous syndromes and pulmonary embolism in SLE, 340ViewpointAid for developing countries, 411Beautifully engineered joints, 296For every ill a pill, 198Really effective meetings, 410The scope of rheumatology, 528Why take up rheumatology? 97
Virus lymphocyte interactions, effect of therapy forconnective tissue disorders, 189 P
Viruses, search for in rheumatoid macrophage-richsynovial cell populations, 159
VISCHER T L see COURTOIS C et alVisual analogue pain scales: correspondence, 414Volvo awards for low back pain research, 412VROOM, T M FELTKAMP- see FELTKAMP-VROOM T M
WALDBERGER M see BECKER G J et alWALKER J R and SMITH M JH An inhibitor of leucocyte
movement in the plasma of patients with rheuma-toid arthritis 563
WALTER J see WOJTULEWSKI J A et al
Index 631
WALTON KW see Scorr D L and WALTON KWVALENTE A J and WALTON KW
WARD P see SCHWARZ H A et alWARREN C see MARTiN M F R et alWARREN R E and BREWERTON D A Faecal carriage of
klebsiella by patients with ankylosing spondylitisand rheumatoid arthritis 37
WATERS A H see MINCHINTON R M et alWATrRE P see DUQUESNOY B et alWEBLEY M, BYROM N A, HOBBS J R and BREWERTON D A
T lymphopenia in acute anterior uveitis andankylosing spondylitis 190P
WEISS S, FISCHEL B and ISCH E S Systemic effects ofintra-articular steroid preparations: correspon-dence, 413
WELSH J see EBRINGER A et alWETrSTEIN P see COURTOIS C et alWHICHER J see MARTIN M F R et alWHrrEHEAD JN see OWSIANIKWD J et alWILKINS E A see GUMPEL JM et alWILLIAMS B D, PUSSELL B A, SEWELL J, LOCKWOOD C M
and NICHOLAS A The pathogenesis of goldinduced post-injection reactions in patients withrheumatoid arthritis 608 P
see also PANAYI G S et alWILLIAMS R C see WILLKENS R F et alWILLKENS R F, RoTH G F, HUSBY G and WILLIAMS R C
Immunocytological studies of lymph nodes inrheumatoid arthritis and malignant lymphoma 147
WILLSHAW H E see EASTMOND C J et alWINROW V R see HALLND et alWOJTULEWSKI J A, Gow P J, WALTER J, GRAHAME R,
GIBSON T, PANAYI G S and MASON J Clotrimazolein rheumatoid arthritis 469
WOLLHEIM F A see SJOBLOM KG et alWOODLAND J, CHAPUT DE SAINTONGE D M, EVANS S J W
and CURREY H L F Azathioprine in rheumatoidarthritis: double-blind trial study of full vs halfdosage vs placebo 604P
WOOLEY P see EBRINGER A et alWRIGHT V Beautifully engineered joints: viewpoint, 296and MOLL J M H Lecturing types. A classification
derived from a detailed analysis of scientificcommunications 193 P
see also BIRD H A et alDIXON J S et alEASTMOND C J et alRHIND V M et al
YAZICI H, CHAMBERLAIN M A, SCHREUDER I, D'AMARO Jand MUFrUOGLU M HLA antigens in Behcet'sdisease: a reappraisal by a comparative study ofTurkish and British patients 344
Yersinia enterocolitica, HLA B27 and ankylosingspondylitis: correspondence, 415
YONEMASU K see OCHI T et alYttrium-90 silicate, radioactivity studies on 2 synovial
specimens after radiation synovectomy with, 87:correspondence, 614
ZAPHIROPOULOS G C see ScoTT D L et alZILKO P J see CHRISTIANSEN K et alZinc, plasma levels, relationship to rheumatoid arthritis
drug treatment and symptoms, 329
Annals of the
Rheumatic Diseases
A journal of clinical rheumatology andconnective tissue research
Editor J. T. Scott
Associate Editors H. L. F. Currey V. Wright
Editorial CommitteeB. M. Ansell John Ball C. G. Barnes E. G. L. BywatersA. M. Denman J. T. Dingle A. St. J. Dixon D. C. DumondeR. B. Duthie D. L. Gardner L. E. Glynn E. B. D. HamiltonE. J. Holborow D. Jackson A. G. Mowat G. NukiK. W. Walton P. H. N. WoodEditor British MedicalJournal
Appointed by the British Medical Association and theArthritis and Rheumatism Council for Research
VOLUME 39, 1980
LONDONBRITISH MEDICAL ASSOCIATIONTAVISTOCK SQUARE WC1H 9JR
;tedacedSScr% ;e4rc'W -aef SV0'4di4ad%Ci4,
Annals of theRheumatic Diseasesis available to junior hospital doctorsin all parts of the world for amaximum of four consecutive years atREDUCED Annual Subscription Rates.(Thereafter, or when reachingconsultant status this special offer willno longer apply.) The followingreduced rates are unchanged for thesix issues published in 1981
Inland £13.00Overseas US$30.00(The full rates are: Inland £28.00; Overseas US$67.00)
The opportunity to subscribe to thisjournal of international authority andrepute at a substantially reducedsubscription rate is one not to bemissed by junior doctors seeking tospecialise in rheumatology.Please complete the adjacent orderform and send for your subscriptionNOW.Further order forms can be suppliedon request.
I-
ORDER FORM I
BMA PublicationsBMA House, Tavistock Square
I London WC1H 9JR, England
Please enter my subscription toANNALS OF THERHEUMATIC DISEASESO United Kingdom and
Irish Republic £13.00D Overseas US$30.00D My remittance for.............
is enclosed(Please tick appropriate boxes)
NAME..........
ADDRESS ................
To be completed by Consultant/ hereby confirm that the abovementioned doctor is a memberof the junior hospital staff!resident/intern at.....................
Annals of the Rheumatic Diseases
IIIIII
S ig ned .........................................
